Gene therapy using ribozymes, RNA that blocks protein production: Phase I and II Update

Chiron Corp. (CHIR), Emeryville, Calif.
Ribozyme Pharmaceuticals Inc.

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE